Sarah Boyce Avista Public Acquisition Corp. Ii (AHPAW) insider trading activity

AHPAW Quotes by TradingView

Sarah Boyce is Director of Avista Public Acquisition Corp. II. Currently has a direct ownership of 68,381 shares of AHPAW, which is worth approximately $47,182. The most recent transaction as insider was on Jun 18, 2024, when has been sold 20,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 68.4K
0% 3M change
48.04% 12M change
Total Value Held $47,182

Sarah Boyce Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 18 2024
BUY
Exercise of conversion of derivative security
-
20,000 Added 22.63%
68,381 Common Stock
Jan 30 2023
BUY
Grant, award, or other acquisition
-
8,753 Added 15.93%
46,190 Common Stock
Nov 01 2022
BUY
Grant, award, or other acquisition
-
37,437 Added 50.0%
37,437 Common Stock

Also insider at

RNA
Avidity Biosciences, Inc. Healthcare
President and CEO
BLI
Berkeley Lights, Inc. Healthcare
Director
LGND
LIGAND PHARMACEUTICALS INC Healthcare
CTNM
Contineum Therapeutics, Inc.
Director
SB

Sarah Boyce

Director
San Diego, CA

Track Institutional and Insider Activities on AHPAW

Follow Avista Public Acquisition Corp. II and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AHPAW shares.

Notify only if

Insider Trading

Get notified when an Avista Public Acquisition Corp. Ii insider buys or sells AHPAW shares.

Notify only if

News

Receive news related to Avista Public Acquisition Corp. II

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AHPAW